Ryan Martins - 17 Feb 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Financial Officer
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Issuer symbol: ETNB
Transactions as of: 17 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Feb 2022, 16:11:49 UTC
Previous filing: 13 Apr 2022
Next filing: 13 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Award	$0	+13,000	+173%	$0.000000	20,500	17 Feb 2022	Direct	F1
transaction	ETNB	Common Stock	Award	$0	+3,000	+15%	$0.000000	23,500	17 Feb 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Award	$0	+52,000		$0.000000	52,000	17 Feb 2022	Common Stock	52,000	$4.44	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2	Represents RSUs that vest in equal installments on each of August 1, 2022, February 1, 2023 and August 1, 2023.
F3	This option represents a right to purchase a total of 52,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.